// App-Quantinova.ai

920-06 : REDUCED DEATH, MYOCARDIAL INFARCTION, AND EARLY STENT THROMBOSIS WITH CANGRELOR VERSUS CLOPIDOGREL ON A BACKGROUND OF BIVALIRUDIN: INSIGHTS FROM CHAMPION PHOENIX

Researchers

Presenter

  • Harvey D. White

Principal Investigators

  • Deepak L. Bhatt

  • C. Michael Gibson

  • Christian W. Hamm

  • Kenneth W. Mahaffey

  • Matthew J. Price

  • Philippe Gabriel Steg

  • Gregg W. Stone

  • Bernardo Cortese

  • Michael Wilensky

Medical Centers

  • Auckland City Hospital, Auckland, New Zealand

Locations

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • Bivalirudin

  • Clopidogrel bisulfate

  • cangrelor

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved